Now in its 13th year, and supported by the Indian Pharmaceutical Associaton, join big pharma players, biotechs, biotech entrepreneurs, key stakeholders including BIRAC, CDSCO and NII, solution providers and associations, from both within India and across the globe at the BioPharma India Convention 2015. Happening at The Westin Mumbai Garden City, Mumbai from 3-4 November, discover the latest developments in India’s biopharma industry, and find out how you can get involved.
With an annual growth rate of 20%, India’s biopharma biotechnology industry is expanding rapidly. Now is the time to get involved in this market, fully understand it, and understand the opportunities it offers.
With three streams and over 60 expert speakers, the conference will cover how India is encouraging innovation and entrepreneurship in biopharma, how to be a part of India’s affordable healthcare initiatives and the opportunity it represents, how to conform with Indian biopharma regulations and protect your IP, how to manufacture quality biologics products at the lowest cost, whilst still ensuring quality, how to utilize QbD, QA, AQ and process design to improve product quality and how to select the right partners to launch successfully into the Indian biopharma market.
Keynote speakers from Lupin, Cadila Pharma Biotechnology, Indian Immunologicals, Clonz Biotech, Stempeutics Research will be demonstrating how they are pushing the boundaries of innovation and entrepreneurship in India’s biopharma industry. Also on hand to share her insights and expertise will be Dr. Renu Swarup, the award-winning head of the National Bio resource Development Board at DBT Managing Director of BIRAC.
Timely, incisive articles delivered directly to your inbox.